Cellosaurus MA09-hRPE (CVCL_C1LA)
Cell line name | MA09-hRPE |
---|---|
Synonyms | MA09-RPE |
Accession | CVCL_C1LA |
Resource Identification Initiative | To cite this cell line use: MA09-hRPE (RRID:CVCL_C1LA) |
Comments | From: Astellas Institute of Regenerative Medicine (AIRM); Marlborough; USA. Biotechnology: Used in clinical trials were it is sub-retinaly transplanted in patients with macular degeneration and Stargardt's macular dystrophy. MA09-hRPE can rescue photoreceptors and prevent loss of vision. Characteristics: The MA09 hESC cell line was terminally differentiated into retinal pigment epithelial (RPE) cells. Omics: Transcriptome analysis by microarray. Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358. Cell type: Retinal pigment epithelial cell; CL=CL_0002586. |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_C344 (MA09) |
Sex of cell | Female |
Age at sampling | Blastocyst stage |
Category | Finite cell line |
Web pages | https://discovery.lifemapsc.com/regenerative-medicine/cell-therapy-applications/eye-ma09-hrpe-human-embryonic-retinal-pigmented-epithelial-cells-for-degenerative-macular-diseases |
Publications | PubMed=19521979; DOI=10.1002/stem.149 PubMed=22281388; DOI=10.1016/S0140-6736(12)60028-2 Patent=US10077424 PubMed=31482011; DOI=10.1038/s41536-019-0081-8; PMCID=PMC6712006 |
Cross-references | |
Encyclopedic resources | Wikidata; Q114311911 |
Entry history | |
Entry creation | 22-Sep-2022 |
Last entry update | 29-Jun-2023 |
Version number | 4 |